SEC Form 4 · accession 0001144204-15-028444
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charlotte C. Arnold
Officer — VP and CFO
Period of report
May 6, 2015
Accepted (ET)
May 7, 2015 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 6, 2015 | M | 4,000 | $6.36 | A | 29,585 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase | $6.36 | May 6, 2015 | M | 4,000 | D | Jul 12, 2014 | Jul 11, 2023 | Common Stock | 4,000 | 40,333 | D |